Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
LeonaBio, Inc. issued 5,356,547 shares of common stock to Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors for $6.35 per share.
- Security
- common stock
- Shares
- 5,356,547 shares
- Purchaser
- Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors
- Consideration
- $6.35 per share
Exact text from the filing
Shares, the “ PIPE Shares ”). The purchase price for each PIPE Initial Share (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.35 and the purchase price for each PIPE Pre-Funded Warrant (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.349 per each underlying
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
LeonaBio, Inc. issued pre-funded warrants to purchase 8,816,684 shares of Common Stock; Series A warrants to purchase 23,031,494 shares; Series B warrants to purchase 21,259,842 shar of warrant to Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors for $6.349 per pre-funded warrant (including accompanying warrants); Series A exercise price $6.35 per share; Series B exercise price $7.62 per share.
- Security
- warrant
- Shares
- pre-funded warrants to purchase 8,816,684 shares of Common Stock; Series A warrants to purchase 23,031,494 shares; Series B warrants to purchase 21,259,842 shar
- Purchaser
- Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors
- Consideration
- $6.349 per pre-funded warrant (including accompanying warrants); Series A exercise price $6.35 per share; Series B exercise price $7.62 per share
Exact text from the filing
Shares, the “ PIPE Shares ”). The purchase price for each PIPE Initial Share (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.35 and the purchase price for each PIPE Pre-Funded Warrant (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.349 per each underlying
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
LeonaBio, Inc. entered into PIPE Securities Purchase Agreement with Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors valued at approximately $90 million (effective 2025-12-18).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors
- Value
- approximately $90 million
- Effective
- 2025-12-18
Exact text from the filing
On December 18, 2025, Athira Pharma, Inc. (the “ Company ” or “ Athira ”) entered into a securities purchase agreement (the “ PIPE Securities Purchase Agreement ”) with a select group of investors, including Commodore Capital LP (“ Commodore ”), TCG Crossover Management LLC (“ TGCX ”), Perceptive Advisors (“ Perceptive ”) and other accredited investors
View on SEC.gov